According to filings with the U.S. Securities and Exchange Commission, Alpha Teknova is raising up to $20,904,987.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Stephen Gunstream played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Alpha Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of state-of-the-art facilities, Teknovas modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies.

To learn more about Alpha Teknova, visit http://teknova.com/
Alpha Teknova Linkedin Page: https://www.linkedin.com/company/teknovascience/

Contact:
Stephen Gunstream, President and Chief Executive Officer
831-637-1100
https://www.linkedin.com/in/stephen-gunstream-21443710/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.